亚太地区生物银行冷冻储存设备市场：分析与预测（2024-2033）

预计亚太地区生物银行保存设备市场规模在 2024 年将达到 2.969 亿美元，到 2033 年将达到 6.479 亿美元，在 2024-2033 年预测期内的复合年增长率为 9.06%。

为了支持基因组学、生物技术和药物研究领域的市场发展，对血液、组织和DNA等生物样本长期储存的需求日益增长，这推动了亚太地区生物银行低温储存设备市场的快速扩张。为了保持样本的完整性和质量，亚太地区的生物银行正在加大对低温储存系统、超低温冷冻库和高性能冷冻设备的投入。市场分为四大类：设备、耗材、软体和服务。由于设备对生物银行的运作至关重要，因此在市场中占据主导地位。

自动化、温度控制和节能製冷技术的进步正在改善样本管理和营运永续性。对临床研究、再生医学和精准医学的日益重视正在推动相关研究。政府支持计划、国家基因组计划以及医疗保健投资的增加正在推动韩国、中国、日本和印度等国的市场成长。此外，日益严格的资料保护和生物安全法规正在推动安全合规的储存基础设备的普及。亚太地区正成为生物银行创新的重要热点地区，随着研发机构、临床试验和生物技术中心的快速发展，该地区在样本储存、扩充性和技术改进方面树立了新的标准。

市场介绍

由于中国、日本、印度、韩国和澳洲在基因组学、生物技术和精准医疗领域取得了显着进展，亚太地区生物银行低温储存设备市场正在快速扩张。该地区的生物银行对于医学研究、临床试验和个人化医疗至关重要，因为它能够保存包括组织、血液、DNA和细胞株在内的各种生物资源。这导致对可靠且高效的低温储存系统（包括低温储存槽、超低温冰箱和自动化样本管理系统）的需求日益增长，以确保生物样本的长期完整性。

政府支持的基因组学倡议、不断增长的医药品研究开发费用以及不断发展的学术和商业性生物银行网络，都在推动市场成长。物联网赋能的温度监控、自动化和节能冷冻等技术进步，正在革新样本保存流程，并提高可追溯性。此外，对生物标记发现和再生医学的日益重视，也推动了相关设备在临床和研究领域的应用。

然而，标准化储存系统和不同的管理体制仍然是主要障碍。儘管如此，随着基础设施的稳定发展和公私合作日益密切，亚太地区正迅速成为全球的生物银行创新中心，为生物医学研究和精准医疗的进步做出贡献。

市场区隔:

细分：按地区

• 亚太地区

亚太地区是生物银行冷冻储存设备市场成长最快的地区。生技和製药产业的快速发展以及研发投入的不断成长，正推动着中国、日本、印度和韩国等国家生物银行的发展。这些国家正在扩大生物银行基础设施，以满足基因组研究、诊断和精准医疗日益增长的需求。医疗保健支出的增加和临床试验的增加也刺激了该地区对先进冷冻储存解决方案的需求。该地区对生物银行能力的持续投资有望继续推动对高效、扩充性冷冻储存设备的需求。

亚太地区生物银行冷冻保存设备市场趋势、驱动因素与挑战：

市场趋势

• 为支持基因组学和临床研究，中国、日本、印度和韩国的生物银行基础设施正在迅速扩展。
• 自动化和物联网冷资料储存系统在即时温度监控和高效样品追踪方面的应用日益广泛。
• 精准医疗和个人化医疗的日益普及将推动对高品质、长期生物样本储存的需求。
• 加强人工智慧和云端基础平台在预测性维护、样品库存管理和数据分析方面的整合。
• 采用节能永续的冷冻技术，最大限度地降低营运成本和环境影响。
• 扩大公私合营和国际伙伴关係，以加强全部区域的生物银行能力和标准化。
• 开发整合 LIMS（实验室资讯管理系统）的数位生物银行，以实现资料管理和增强合规性。

市场驱动因素

• 政府大力资助和国家基因组计划（例如中国的精准医疗计划、印度的基因组计划）以促进生物银行和精准医疗的发展。
• 製药和生物技术公司研发投入的增加将推动对先进冷冻保存解决方案的需求。
• 亚太地区医疗保健生态系统中临床试验和生物标记发现计画不断增加。
• 需要超低温和冷冻保存的再生医学和细胞疗法研究的扩展。
• 生物医学研究中越来越重视生物样本的品质、可追溯性和法规遵循。
• 技术进步使得大规模生物银行操作的自动化、扩充性和远端监控成为可能。

市场挑战

• 超低温和低温储存系统的安装和维护成本高。
• 由于亚太地区各国监管不一致，导致生物银行标准分散化。
• 低温运输管理、生物银行运作和数据分析方面缺乏熟练人员。
• 由于持续的超低温运行和不断上涨的电费，人们对能源消耗表示担忧。
• 跨国研究合作中的资料隐私和生物样本管治问题。
• 对进口设备和零件的依赖、不断上涨的采购成本以及供应链的脆弱性。

本报告深入剖析了生物银行低温储存设备的最新进展，包括温度控制、自动化和云端基础监控系统等方面的创新。企业可以利用这些见解，发掘产品差异化机会，开发新一代低温储存解决方案，并整合最尖端科技，以满足生物银行和个人化医疗日益增长的需求。

该报告详细分析了各个地区和细分市场，使企业能够瞄准生物银行基础设施需求快速成长的高成长地区。了解市场趋势和区域动态将有助于企业调整行销策略，并在高成长地区有效定位其产品，以满足日益增长的先进冷冻保存解决方案的需求。

透过分析市场份额、主要参与企业和行业趋势，公司可以评估竞争动态，识别市场领导，并製定策略以获得竞争优势，包括建立策略伙伴关係、进入新市场以及开发创新产品以满足生物银行和研究机构不断变化的需求。

目录

执行摘要

1. 亚太地区生物银行低温恆温器市场概览

• 市场概览
• 法律规范
  • 日本
  • 中国
  • 巴西
• 专利分析
  • 专利申请趋势（按国家/地区划分）
  • 专利申请趋势（按年份）
• 生物银行保存设备市场、供应链与价值链分析
• 市场动态概述
  • 市场驱动因素
  • 市场限制
  • 市场机会

第二章生物银行冷冻保存设备市场（按地区划分），百万美元，2022-2033年

• 区域摘要
• 亚太地区
  • 区域概览
  • 市场成长驱动因素
  • 成长抑制因素

第三章 市场竞争情势

• 生物银行冷冻保存设备市场：竞争格局
  • 策略发展，2021年1月至2024年12月
• 公司简介
  • PHC Holding Corporation
  • Haier Biomedical
  • MGI Tech Co., Ltd.
  • Esco Micro Pte. Ltd.

第四章调查方法

This report can be delivered in 2 working days.

Introduction to Asia-Pacific Biobanking Cold Storage Equipment Market

The Asia-Pacific biobanking cold storage equipment market was valued at $296.9 million in 2024 and is anticipated to reach $647.9 million by 2033, witnessing a CAGR of 9.06% during the forecast period 2024-2033. The growing requirement for long-term preservation of biological samples, such as blood, tissues, and DNA, to support developments in genomics, biotechnology, and pharmaceutical research is driving the rapid expansion of the APAC Biobanking Cold Storage Equipment Market. To preserve sample integrity and quality, biobanks throughout Asia-Pacific are investing more in cryogenic storage systems, ultra-low temperature freezers, and sophisticated refrigeration units. The market is divided into four categories: equipment, consumables, software, and services. Because equipment is crucial to biobanking activities, it dominates the market.

Automation, temperature control, and energy-efficient refrigeration technological advancements are enhancing sample management and operational sustainability. Adoption is being accelerated by the area's increasing focus on clinical research, regenerative medicines, and precision medicine. The market is expanding because to supportive government initiatives, national genomics projects, and rising healthcare investments in nations like South Korea, China, Japan, and India. Additionally, the implementation of safe and compliant storage infrastructure is being encouraged by the growing regulatory focus on data protection and biosafety. The APAC area is becoming a significant hotspot for biobanking innovation, setting new standards in sample preservation, scalability, and technological improvement with the quick growth of R&D facilities, clinical trials, and biotechnology centers.

Market Introduction

The APAC Biobanking Cold Storage Equipment Market is expanding rapidly, owing to significant advances in genomics, biotechnology, and precision medicine in China, Japan, India, South Korea, and Australia. Because they preserve a variety of biological resources, such as tissues, blood, DNA, and cell lines, biobanks around the region are essential to medical research, clinical trials, and personalized healthcare initiatives. As a result, there is an increasing need for dependable and effective cold storage systems that guarantee long-term biosample integrity, such as cryogenic storage tanks, ultra-low temperature freezers, and automated sample management systems.

Government-backed genomics initiatives, rising pharmaceutical R&D expenditures, and a developing network of academic and commercial biobanks all contribute to the market's growth. IoT-enabled temperature monitoring, automation, and energy-efficient refrigeration are examples of technological advancements that are modernizing sample storage processes and improving traceability. Additionally, equipment use in clinical and research settings is increasing due to the rising emphasis on biomarker discovery and regenerative medicine.

Standardized storage systems and disparate regulatory regimes, however, continue to be major obstacles. Nevertheless, the APAC area is quickly becoming a global center for biobanking innovation, improving biomedical research and precision healthcare, thanks to robust infrastructure development and growing cooperation between the public and private sectors.

Market Segmentation:

Segmentation : by Region

• Asia-Pacific

The Asia-Pacific region is the fastest-growing market for biobanking cold storage equipment. Rapid advancements in biotechnology and pharmaceuticals, coupled with increasing research investments, drive the growth of biobanks in countries like China, Japan, India, and South Korea. These countries are expanding their biobanking infrastructure to support the growing demand for genomics research, diagnostics, and precision medicine. The rise in healthcare expenditures and the increasing number of clinical trials in the region also stimulate demand for advanced cold storage solutions. As the region continues to invest in biobanking capabilities, the demand for efficient and scalable cold storage equipment will continue to rise.

APAC Biobanking Cold Storage Equipment Market Trends, Drivers and Challenges:

Market Trends

• Rapid expansion of biobanking infrastructure across China, Japan, India, and South Korea to support genomic and clinical research.
• Growing adoption of automated and IoT-enabled cold storage systems for real-time temperature monitoring and efficient sample tracking.
• Increased focus on precision medicine and personalized healthcare, driving the need for high-quality, long-term biosample preservation.
• Rising integration of AI and cloud-based platforms for predictive maintenance, sample inventory management, and data analytics.
• Adoption of energy-efficient and sustainable refrigeration technologies to minimize operational costs and environmental impact.
• Growing public-private collaborations and international partnerships to strengthen biobanking capacity and standardization across the region.
• Development of digital biobanks integrating LIMS (Laboratory Information Management Systems) for enhanced data management and compliance.

Market Drivers

• Strong government funding and national genomics programs promoting biobanking and precision medicine (e.g., China's Precision Medicine Initiative, India's Genome Project).
• Increasing pharmaceutical and biotech R&D investments, boosting demand for advanced cold storage solutions.
• Rising number of clinical trials and biomarker discovery programs across APAC healthcare ecosystems.
• Expansion of regenerative medicine and cell therapy research, requiring ultra-low temperature and cryogenic preservation.
• Growing emphasis on biosample quality, traceability, and regulatory compliance in biomedical research.
• Technological advancements enabling automation, scalability, and remote monitoring for large-scale biobank operations.

Market Challenges

• High setup and maintenance costs of ultra-low temperature and cryogenic storage systems.
• Regulatory inconsistencies across APAC countries, leading to fragmented biobanking standards.
• Limited skilled workforce in cold chain management, biobank operations, and data analytics.
• Energy consumption concerns due to continuous ultra-low temperature operations and rising electricity costs.
• Data privacy and biosample governance issues in cross-border research collaborations.
• Dependence on imported equipment and components, increasing procurement costs and supply chain vulnerabilities.

How can this report add value to an organization?

Product/Innovation Strategy: This report provides valuable insights into the latest advancements in biobanking cold storage equipment, including innovations in temperature control, automation, and cloud-based monitoring systems. Organizations can use these insights to identify opportunities for product differentiation, develop next-generation cold storage solutions, and integrate cutting-edge technologies to meet the growing demands of biobanks and personalized medicine.

Growth/Marketing Strategy: The report offers detailed regional and market segment insights, enabling organizations to target high-growth, where demand for biobanking infrastructure is rapidly expanding. By understanding market trends and regional dynamics, companies can align their marketing strategies to effectively position their products in fast-growing regions, capitalizing on the increasing need for advanced cold storage solutions.

Competitive Strategy: By analyzing market share, key players, and industry trends, this report allows organizations to evaluate competitive dynamics, identify market leaders, and develop strategies to gain a competitive edge. This can include forming strategic partnerships, entering new markets, and developing innovative product offerings to meet the evolving needs of biobanks and research institutions.

Table of Contents

Executive Summary

Scope and Definition

1 Asia-Pacific Biobanking Cold Storage Equipment Market: Overview

• 1.1 Market Overview
• 1.2 Regulatory Framework
  • 1.2.1 Japan
    • 1.2.1.1 Regulatory Requirements for Biobanking Cold Storage Equipment Intended as Medical Devices
  • 1.2.2 China
    • 1.2.2.1 Regulatory Requirements for Biobanking Cold Storage Equipment Intended as Medical Devices
  • 1.2.3 Brazil
• 1.3 Patent Analysis
  • 1.3.1 Patent Filing Trend (by Country)
  • 1.3.2 Patent Filing Trend (by Year)
• 1.4 Biobanking Cold Storage Equipment Market, Supply/ Value Chain Analysis
• 1.5 Market Dynamics Overview
  • 1.5.1 Market Drivers
    • 1.5.1.1 Growing Investments and Funding for Biobanks
    • 1.5.1.2 Increasing R&D Activities Using Biospecimens in Precision Medicine
    • 1.5.1.3 Technological Advancements and Automation in Biobanking
    • 1.5.1.4 Increasing Trend in Preservation of Cord Blood Stem Cells from Newborns
  • 1.5.2 Market Restraints
    • 1.5.2.1 Elevated Operational Costs for Biobanks
    • 1.5.2.2 High Legal and Ethical Challenges
  • 1.5.3 Market Opportunities
    • 1.5.3.1 Emerging Economies to Provide Lucrative Opportunities

2 Biobanking Cold Storage Equipment Market (By Region), $Million, 2022-2033

• 2.1 Regional Summary
• 2.2 Asia-Pacific
  • 2.2.1 Regional Overview
  • 2.2.2 Driving Factors for Market Growth
  • 2.2.3 Factors Challenging the Market
    • 2.2.3.1 China
    • 2.2.3.2 Japan
    • 2.2.3.3 Australia
    • 2.2.3.4 India
    • 2.2.3.5 Singapore
    • 2.2.3.6 Rest-of-Asia-Pacific

3 Markets - Competitive Landscape

• 3.1 Biobanking Cold Storage Equipment Market: Competitive Landscape
  • 3.1.1 Strategic Developments, January 2021- December 2024
• 3.2 Company Profiles
  • 3.2.1 PHC Holding Corporation
    • 3.2.1.1 Overview
    • 3.2.1.2 Top Products Offered
    • 3.2.1.3 Top Competitors
    • 3.2.1.4 Target Customers/End Users
    • 3.2.1.5 Analyst View
  • 3.2.2 Haier Biomedical
    • 3.2.2.1 Overview
    • 3.2.2.2 Top Products Offered
    • 3.2.2.3 Top Competitors
    • 3.2.2.4 Target Customers/End Users
    • 3.2.2.5 Analyst View
  • 3.2.3 MGI Tech Co., Ltd.
    • 3.2.3.1 Overview
    • 3.2.3.2 Top Product Offered
    • 3.2.3.3 Top Competitors
    • 3.2.3.4 Target Customers/End Users
    • 3.2.3.5 Analyst View
  • 3.2.4 Esco Micro Pte. Ltd.
    • 3.2.4.1 Overview
    • 3.2.4.2 Top Products Offered
    • 3.2.4.3 Top Competitors
    • 3.2.4.4 Target Customers/End Users
    • 3.2.4.5 Analyst View

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast

List of Figures

• Figure 1: Asia-Pacific Biobanking Cold Storage Equipment Market, $Million, 2024, 2028, and 2033
• Figure 2: Biobanking Cold Storage Equipment Market (by Region), $Million, 2023, 2027, and 2033
• Figure 3: Number of Patents in Biobanking Cold Storage Equipment Market (by Country), January 2019-May 2024
• Figure 4: Number of Patent in Biobanking Cold Storage Equipment Market (by Year), January 2011-December 2024
• Figure 5: Supply/ Value Chain Analysis: Biobanking Cold Storage Equipment Market
• Figure 6: Legal and Ethical Challenges in Biobanking
• Figure 7: China Biobanking Cold Storage Equipment Market, $Million, 2022-2033
• Figure 8: Japan Biobanking Cold Storage Equipment Market, $Million, 2022-2033
• Figure 9: Australia Biobanking Cold Storage Equipment Market, $Million, 2022-2033
• Figure 10: India Biobanking Cold Storage Equipment Market, $Million, 2022-2033
• Figure 11: Singapore Biobanking Cold Storage Equipment Market, $Million, 2022-2033
• Figure 12: Rest-of-Asia-Pacific Biobanking Cold Storage Equipment Market, $Million, 2022-2033
• Figure 13: Strategic Developments, January 2021- December 2024
• Figure 14: Data Triangulation
• Figure 15: Top-Down and Bottom-Up Approach
• Figure 16: Assumptions and Limitations

List of Tables

• Table 1: Market Snapshot
• Table 2: Asia-Pacific Biobanking Cold Storage Equipment Market Opportunities
• Table 3: Impact Analysis of Market Navigating Factors, 2022-2033
• Table 4: Operational and Direct Labor Costs
• Table 5: Biobanking Cold Storage Equipment Market (by Region), $Million, 2022-2033
• Table 6: Asia-Pacific Biobanking Cold Storage Equipment Market (by Country), $Million, 2022-2033